阿拉丁 |
T127762-25mg |
25mg |
现货 |
639089-54-6 |
陶扎色替 Tozaserti |
≥98% |
479.90
479.90
|
|
阿拉丁 |
T127762-100mg |
100mg |
现货 |
639089-54-6 |
陶扎色替 Tozaserti |
≥98% |
1,647.90
1,647.90
|
|
阿拉丁 |
T407973-1ml |
1ml |
期货,请咨询 |
639089-54-6 |
Tozasertib (VX-680, MK-0457) Tozasertib (VX-680, MK-0457) |
10mM in DMSO |
240.90
240.90
|
|
罗恩 |
R020384-25mg |
25mg |
5~7个工作日 |
639089-54-6 |
陶扎色替 Tozaserti |
98% |
565.00
565.00
|
|
罗恩 |
R020384-100mg |
100mg |
5~7个工作日 |
639089-54-6 |
陶扎色替 Tozaserti |
98% |
1,977.00
1,977.00
|
|
麦克林 |
T863610-25mg |
25mg |
咨询客服 |
639089-54-6 |
皮考林羧酸N-氧化物 Tozaserti |
≥98% |
483.00
483.00
|
|
毕得 |
BD161453-25mg |
25mg |
现货 |
639089-54-6 |
N-(4-((4-((5-甲基-1H-吡唑-3-基)氨基... N-(4-((4-((5-Methyl-1H-pyraz... |
99+% |
280.00
280.00
|
|
毕得 |
BD161453-50mg |
50mg |
现货 |
639089-54-6 |
N-(4-((4-((5-甲基-1H-吡唑-3-基)氨基... N-(4-((4-((5-Methyl-1H-pyraz... |
99+% |
476.00
476.00
|
|
毕得 |
BD161453-100mg |
100mg |
现货 |
639089-54-6 |
N-(4-((4-((5-甲基-1H-吡唑-3-基)氨基... N-(4-((4-((5-Methyl-1H-pyraz... |
99+% |
808.00
808.00
|
|
毕得 |
BD161453-250mg |
250mg |
现货 |
639089-54-6 |
N-(4-((4-((5-甲基-1H-吡唑-3-基)氨基... N-(4-((4-((5-Methyl-1H-pyraz... |
99+% |
1,829.00
1,829.00
|
|
毕得 |
BD161453-10mg |
10mg |
现货 |
639089-54-6 |
N-(4-((4-((5-甲基-1H-吡唑-3-基)氨基... N-(4-((4-((5-Methyl-1H-pyraz... |
99+% |
140.00
140.00
|
|